These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3519464)

  • 1. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
    Vreede RW; Marcelis JH; Verhoef J
    Infect Immun; 1986 Jun; 52(3):892-6. PubMed ID: 3519464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.
    Crowley JP; Zinner SH; Peter G
    J Lab Clin Med; 1982 Feb; 99(2):197-205. PubMed ID: 7038008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the opsonic activity of polyclonal and monoclonal antibodies raised against Salmonella minnesota strain R595.
    Mehta ND; Wilson BM; Rapson NT; Easmon CS
    J Med Microbiol; 1988 Feb; 25(2):85-93. PubMed ID: 2448462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
    Greisman SE; Johnston CA
    J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing complement-mediated opsonic activity of rabbit interstitial fluids from autologous serum.
    Lam C; Georgopoulos A; Schütze E
    Comp Immunol Microbiol Infect Dis; 1988; 11(1):1-9. PubMed ID: 3289826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H; Verbrugh HA; Heezius HC; Renders NH; Fleer A; van der Meulen J; Oe PL; Verhoef J
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
    Wise AJ; Hogan JS; Takemura K; Smith KL
    J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
    Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
    de Jongh-Leuvenink J; Vreede RW; Marcelis JH; de Vos M; Verhoef J
    Infect Immun; 1985 Dec; 50(3):716-20. PubMed ID: 3905612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.